Infinium Pharmachem Limited (NSE:INFINIUM)
India · Delayed Price · Currency is INR 227.75
+7.75 (3.52%)
Aug 21, 2026, 3:23 PM IST
Infinium Pharmachem Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 121.5 | 81.45 | 113.02 | 94.9 | 61.06 |
Depreciation & Amortization | 30.61 | 32.95 | 26.68 | 13.39 | 6.31 |
Other Operating Activities | 40.67 | 33.47 | 25.29 | 34.37 | 22.74 |
Change in Accounts Receivable | 22.85 | -132.94 | -50.21 | -0.4 | -39.05 |
Change in Inventory | 52.02 | -195.6 | -49.77 | -33.56 | -69.77 |
Change in Accounts Payable | -83.13 | 78.73 | -23.15 | -49.89 | -0.62 |
Change in Other Net Operating Assets | 173.32 | -192.3 | 9.32 | 30.37 | 143.07 |
Operating Cash Flow | 337.34 | -291.23 | 49.18 | 85.9 | 117.96 |
Operating Cash Flow Growth | - | - | -42.75% | -27.18% | 73.06% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -96.85 | -52.53 | -35.12 | -74.66 | -47.27 |
Cash Acquisitions | - | -33.95 | - | - | - |
Divestitures | 20.75 | 138.8 | 2.33 | 4.01 | - |
Investment in Securities | - | -290.25 | - | - | - |
Other Investing Activities | 5.25 | -33.38 | -4.71 | 23.05 | -18.59 |
Investing Cash Flow | -72.38 | -272.42 | -37.94 | -49.56 | -66.32 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 384.11 | - | - | - |
Long-Term Debt Issued | 2.38 | 21.91 | - | - | - |
Total Debt Issued | 2.38 | 406.02 | - | - | - |
Short-Term Debt Repaid | -266.33 | - | -157.41 | - | - |
Long-Term Debt Repaid | -23.58 | - | -22.55 | - | - |
Total Debt Repaid | -289.91 | - | -179.95 | - | - |
Net Debt Issued (Repaid) | -287.54 | 406.02 | -179.95 | - | - |
Issuance of Common Stock | - | 439.76 | 252.57 | - | - |
Other Financing Activities | -28.02 | -52.86 | -24.53 | -31.05 | -17.03 |
Financing Cash Flow | -315.56 | 792.92 | 48.08 | -31.05 | -17.03 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -50.6 | 229.28 | 59.32 | 5.28 | 34.62 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 240.49 | -343.76 | 14.06 | 11.23 | 70.69 |
Free Cash Flow Growth | - | - | 25.14% | -84.11% | 219.67% |
Free Cash Flow Margin | 12.68% | -22.08% | 1.04% | 0.98% | 7.13% |
Free Cash Flow Per Share | 15.44 | -23.64 | 1.32 | 1.10 | 6.95 |
Levered Free Cash Flow | 197.64 | -394.34 | -34.52 | -107.44 | -69.66 |
Unlevered Free Cash Flow | 215.16 | -378.76 | -22.94 | -89.98 | -60.66 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 28.02 | 36.72 | 21.57 | 31.05 | 14.4 |
Cash Income Tax Paid | 37.34 | 38.59 | 36.72 | 31.2 | 19.57 |
Change in Working Capital | 165.06 | -442.11 | -113.81 | -53.48 | 33.63 |